During the past decade, catheter ablation of atrial fibrillation (AF) has emerged as an important treatment option for patients with symptomatic AF refractory to antiarrhythmic drug therapy.
The 2012 HRS/EHRA/ECAS Expert Consensus Document on Catheter Ablation of Atrial
Fibrillation provides a Class 1 Level of Evidence A recommendation for catheter ablation of AF in patients with paroxysmal atrial fibrillation who have failed treatment with at least one antiarrhythmic medication and a Class 2 Level of Evidence B recommendation for patients with paroxysmal AF who have not failed antiarrhythmic drug therapy 1 .
In the present issue of Circulation, Deshmukh et al. 2 States community hospitals. Complications were broken down into five groups; cardiac complications, vascular complications, respiratory complications, neurologic complications, and infectious complications. In-hospital mortality was also determined. Delayed complications which commonly present after hospital discharge including pulmonary vein stenosis and atrial esophageal fistula could not be evaluated. The data was analyzed to identify predictors of complications, and also to determine the relationship between operator and hospital volume with the incidence of complications. There were five main findings of this study. First, most of the AF ablation procedures (81%) were performed by operators doing less than 25 AF ablation procedures per year, and in hospitals with annual AF ablation volumes less than 50. Second, the overall complication rate was 6.3% and the overall in-hospital mortality was 0.42%. The frequency of complications increased from 5.3% in 2000 to 7.5% in 2010. Third, the incidence of complications was increased in elderly patients and AF ablation in women had a 2% higher . It is also reassuring to me that several of the conclusions of this study, such as the increased risk of complications in women and in the elderly are well aligned with data we have published from our single center ablation registry 7, 8 .
I believe that the results of this study are unique, important, and sobering. The uniqueness of this study rests in its size and scope as well as the fact that these are "real world" data obtained from smaller hospitals and lower volume operators. More than 80% of the 93,801
AF ablation procedures were performed by operators with an annual AF ablation volume less It is my opinion that the results of this study are valid. While it is easy to o c c cri ri riti ti ici ci cize ze ze t t the he he many assumptions needed to perform this analysis (including the absence of a procedure code for AF AF F a a abl bl blat at a io io ion) ), , to to to identify the limitations inhe ere re rent nt n to data derived fro ro om m m administrative data ba ba ase e es, s and t to o ar ar rg gu gue e e th th hat at t t th he hese se s f f fin in indi di ding ng ngs s s ar ar re e ou ou outd td t at a e e ed d (> 3 3 3 y y yea ea e rs rs r o o ol ld ld), ), ), I I I b b b l el elie ie i ve ve e t t tha ha hat t t st st stre reng n ngth th th c c com om mes fr fr rom om om numbe ers rs rs an nd nd tha at t t th he re re esu u ult l s of of of t th h his s s stu u udy y y are e e v va vali li lid. d. d. I It t is s str rik ki ing g t t tha at at t the he he o ove v r ra ral ll ll co co comp mp mpli li lica ca cati ti tion on on r r rat at ate e e (6 (6 (6 3 .3 .3%) %) %) i i is s s vi vi virt rt rtua ua uall ll lly y y id id iden en enti ti tica ca cal l l to to to t t the he he 6 6 6% % % an an and d d 4 4. 4.5% 5% 5% c c com om ompl pl plic ic icat at atio io ion n n ra ra rate te tes s s re re repo po port rt rted ed ed i i in n n than 25. The importance of this study results from the significance of these findings. As physicians we are all bound by the phrase "Primum non nocere; first, do no harm".
And as electrophysiologists we perform AF ablation procedures to improve quality of life. A 6.3% overall complication rate (not including serious delayed complications such as PV stenosis and atrial esophageal fistula) and one in-hospital death for every 238 patients undergoing AF ablation is not in keeping with this. The results of this study are sobering on many fronts. First, it appears that complication rates of AF ablation when viewed broadly are not falling and in fact may be increasing. This contrasts from our own tertiary care hospital experience where our complication rate has dropped from 11.1% to 1.6% over a 10 year period, with no deaths 8 . Furthermore, in the past five years there have been no complications with a permanent sequellae 8 . Secondly, complication rates were age related increasing to 9.4% in patients over 80 years. To the extent that advanced age is the most powerful predictor of AF, the clinical implications of this finding should be clear to all. And third, complication rates were dramatically and powerfully impacted both by operator volume and hospital AF ablation volume.
While perhaps predictable, the clinical impact of this finding is enormous as more than 80% of AF ablation procedures were performed by operators performing less than 25 AF ablation procedures per year. This annual AF ablation volume is below the volume recommended in the 2012 HRS/EHRA/ECAS Expert Consensus Document which states that recommends that electrophysiologists should perform at least 50 AF ablation procedures during training and then should perform "several procedures for AF per month if they intend to remain active in this area 1 ."
And finally, what are the implications of the results of this study for interested parties?
First, the results of this study should remind electrophysiologists of the complexity of AF ablation procedures and the very significant risk associated with these procedures, especially with no deaths 8 . Furthermore, in the past five years there have been no complicat atio io ions ns ns w w wit it ith h h a a a permanent sequellae 8 . Secondly, complication rates were age related increasing to 9.4% in pati tien en nts ts ts o o ove ve v r r r 80 80 y y yea ea e rs. To the extent that advance ce ed d d age is the most po owe we werf r ul predictor of AF, the cl cl lin ni ic ical imp pli li ica ca ati ti tion on ns s of of of t t thi hi his s fi fi ind nd ndin in ing g g sh sh hou ou uld ld d b b be e cl clea a ar r to a a all ll ll. . An An And d th th thir r rd, d, d c c com om mplic ic cat at atio io ion n ra ra r te te tes s we we were re r dr dr ram am amatically ly y a a and d p p powe erf f full ly y im m mpa pact ct ted ed e b bo oth by by y op pe er r rato to or vo vol lum m me a an n nd ho o osp pi pita ta al A AF AF a ab bl bla a atio on n n vo olu lum me Wh Wh Whil il ile e e pe pe perh rh rhap ap aps s s pr pr pred ed edic ic icta ta tabl bl ble e, e, t t the he he c c cli li lini ni nica ca cal l l im im impa pa pact ct ct o o of f f th th this is is f f fin in indi di ding ng ng i i is s s en en enor or ormo mo mous us us a a as s s mo mo more re re t t tha ha han n n 80 80 80% % % of of of the results of this study should be carefully considered by industrial partners who manufacture technology used for AF ablation. There clearly is room for both the perfection of current ablation technologies to make them more "user friendly" and the development of new ablation technologies. But it is notable that high volume operators appear to be able to employ currently available ablation technology safely and effectively. And finally, the results of this study need to be considered by patients who are making the final decision concerning who will perform their ablation procedure and where it will be performed.
At the end of the day, I think this paper is a welcome addition to the literature. Not only does it provide new and important information concerning complications of AF ablation, but it needed to safely carry out this procedure with case volumes less than the recomm mm men en ende de ded d d minimum of "several per month". Second, the results of this study should be considered by hosp sp pit it tal al al c c com om ommi m m tt tt tee ee ees s that grant clinical privileges es s. . Wh W W ile there is an in nhe he here re r nt conflict between the de de desi i ire r of ho osp spit it tal al als to o o p p per er rf fo form rm rm m m mor or ore e e re re eve ve v nu nu ue e e ge gene n r ra rat ting g g p p pro ro roce ce edu du ure r r s s s an an and d d th th t e gr gr gran an anti ti ting ng ng o o of f f cl cl clin in inic ic ical al a pr pr riv iv ivil il i eg ges, in n n the e lo o ong g te e erm m t t the he e p pub bli li lic c is is n not t w w well se serv rved ed ed i if f t t the e ese pr r rivile eg eges es a a are re e g gra an nt nted ed to o o op op oper er erat at ator or ors s s wh wh who o o do do do n n not ot ot h h hav av ave e e th th the e e sk sk skil il ills ls ls a a and nd nd c c com om ommi mi mitm tm tmen en ent t t to to to p p per er erfo fo form rm rm t t the he hese se se p p pro ro roce ce cedu du dure re res s s sa sa safe fe fely ly ly. . Th Th Thir ir ird d, d, h l f hi d h ldb f ll id db i d i l h f also helps launch an important discussion among those interested in this rapidly growing field.
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